Decision Makers
| Name (plus bio) |
Position |
| Matthew W. Emmens |
CEO |
| David E Shaw |
President |
| Freda C. Lewis-Hall |
Executive Vice President, Medicines Development and Chief Medical Officer |
| Ian F. Smith |
Executive Vice President and Chief Financial Officer |
| John Alam |
Executive Vice President, Med. Dev. Group & Cmo |
| Kurt C Graves |
Executive Vice President, Chief Commercial Officer |
| Peter Mueller |
Executive Vice President Drug Innov.& Realiz, Cso |
| Valerie Andrews |
Chief Compliance Officer |
| Victor A. Hartmann |
Executive Vice President, Strategic & Corp Development |
| Amit K Sachdev |
Senior Vice President, Public Policy,Gov Affairs |
| Kenneth Boger |
General Counsel & Senior Vice President |
| Lisa Kelly |
Senior Vice President, Human Resources |
| Richard C Garrison |
Senior Vice President and Catalyst |
| Iain Buchanan |
Managing Director, Vertex Pharmaceuticals Limited & Vice President, European Operations |
| Johanna Messina Power |
Vice President & Controller |
| Kerry Reinertsen |
Vice President, Corp and Business Development |
| Michael Partridge |
Vice President, Investor Relations |
| Paul M. Silva |
Vice President and Corporate Controller (Principal Accounting Officer) |
| Josh Boger |
Founder |
| Joshua Boger |
Founder |
| Lora Pike |
Associate Director, Investor Relations |
| Majda Benhayoun |
Director of Program and Portfolio Management |
| Patricia Farrell |
Director of Public Relations |
| Paul Anderson |
Director, Advisory |
| Stephanie Marrus |
Director, Corp Communications |
| Zachry Barber |
Media Relations Manager |
| Bruce Sachs |
Director |
| Stuart J. Collinson |
Director |
Board of Directors
| Organization |
Position |
Status |
| Incyte Corporation |
Chief Executive Officer, Chairman of the Executive Committee |
Current |
| The S.H.I.R.E |
Chief Executive Officer |
Current |
| Shire plc |
Chairman |
Current |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Shire Acquisition Inc. |
Board of Directors |
Current |
| The S.H.I.R.E |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Committee Member |
Current |
| Emd Pharmaceuticals, Inc. |
Chief Executive Officer |
Former |
| Vertex Pharmaceuticals Incorporated |
CEO |
Former |
| Shire plc |
Chief Executive Officer |
Former |
| Shire Acquisition Inc. |
Chief Executive Officer |
Former |
| Vertex Pharmaceuticals Incorporated |
President |
Former |
| Incyte Corporation |
Board of Directors |
Current |
| Fairleigh Dickinson University |
B.S. Degree In Business Management |
Former |
| Merck & Co. Inc. |
|
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
President |
Current |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Executive Vice President, Medicines Development and Chief Medical Officer |
Current |
| Pfizer Inc. |
Senior Vice President & Chief Medical Officer |
Current |
| Bristol-Myers Squibb Company |
Senior Vice President, Medical Affairs |
Former |
| Pharmacia Corporation |
Vice President, Research & Development |
Former |
| Eli Lilly and Company |
Product Team Leader |
Former |
| Howard University Hospital |
Medical Doctorate |
Former |
| The Johns Hopkins University |
Bachelor of Arts & Sciences Degree |
Former |
Ian Smith joined Vertex in November 2001. Prior to joining Vertex, Mr. Smith served as a partner in the Life Science and Technology Practice Group of Ernst & Young LLP, an accounting firm, from 1999 to 2001. As Vertex’s CFO, Mr. Smith holds responsibility for a wide variety of core functions at Vertex, including Finance, Strategic Communications, Information Systems and Operations. Mr. Smith is also a member of the Executive Team at Vertex.
Mr. Smith received a B.A. with honors in Accounting and Finance from Manchester Metropolitan University. Mr. Smith is a current member of the American Institute of Certified Public Accountants, the Institute of Chartered Accountants of England and Wales, and the Financial Executives Institute.
Mr. Smith is a member of the Board of Directors of Acorda Therapeutics, Inc, Epix Pharmaceuticals, Inc. and TolerRx Inc. Additionally, he is a board member of the Massachusetts Biotechnology Council and is Chair of its Policy Committee.
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Executive Vice President and Chief Financial Officer |
Current |
| Vertex, Inc. |
Executive Vice President |
Current |
| Infinity Pharmaceuticals, Inc |
Chair |
Current |
| Acorda Therapeutics, Inc. |
Board of Directors |
Current |
| TolerRx, Inc. |
Board of Directors |
Current |
| Predix Pharmaceuticals Holdings, Inc. |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Prohost Biotechnology |
Board of Directors |
Current |
| American Institute of Certified Public Accountants |
Member |
Current |
| Vertex, Inc. |
Chief Financial Officer |
Former |
| Vertex Pharmaceuticals Incorporated |
Senior Vice President |
Former |
| Vertex, Inc. |
Senior Vice President |
Former |
| Vertex, Inc. |
Vice President |
Former |
| Life Science!, Inc |
Partner |
Former |
| Ernst & Young |
partner |
Former |
| Manchester Metropolitan University |
B.A. with honors in accounting |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Executive Vice President, Med. Dev. Group & Cmo |
Current |
| Vertex Pharmaceuticals Incorporated |
Senior Vice President |
Former |
Mr. Graves joined in July 2007 to lead Vertex’s strategic development and commercial functions as well as the business development group.
Prior to joining Vertex, Mr. Graves held various executive positions at Novartis Pharmaceuticals from 1999 to present, most recently as Global Head of General Medicines Business Unit & Chief Marketing Officer, Pharmaceuticals. Prior to that, Mr. Graves served as Senior Vice President & General Manager – US Pharma & Commercial Operations; Vice President, Head of US Marketing & Primary Care Franchises; and Vice President & Business Unit Head: Respiratory, GI, Dermatology and Bone Franchises. Prior to joining Novartis, Mr. Graves was GI Business Unit Head – US Gastrointestinal Franchise, at Astra Pharmaceuticals, LP from 1997 to 1998. From 1993 to 1997, Mr. Graves served in a variety of roles at Astra Merck Pharmaceuticals including Executive Director, Business Unit Commercialization Leader. He has extensive training in marketing & sales and general management from prestigious institutions, including the University of Michigan Business School, Wharton School of Business and Harvard Business School. He earned his B.S. in Biology from Hillsdale College.
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Executive Vice President, Chief Commercial Officer |
Current |
Dr. Mueller currently serves as our Executive Vice President, Global Research and Development, and Chief Scientific Officer, a position he assumed in May 2009. Dr. Mueller has been with Vertex since 2003. He is responsible for Vertex's research and development, including clinical and non-clinical development, clinical operations and medical and regulatory affairs for all of Vertex's drug candidates.
Prior to joining Vertex, Dr. Mueller was the Senior Vice President, Research and Development, of Boehringer Ingelheim Pharmaceuticals, Inc., with responsibility for the development of all drug candidates in the company’s worldwide portfolio in North America. In the US he also led research programs in the areas of immunology, inflammatory cardiovascular disease and gene therapy on a global basis. During his time with Boehringer Ingelheim, Dr. Mueller oversaw the discovery, development and approval of numerous development candidates and held several positions in basic research, medicinal chemistry and management. Dr. Mueller received both an undergraduate degree and a Ph.D. in chemistry at the Albert Einstein University of Ulm, Germany, where he also holds a Professorship in Theoretic Organic Chemistry. He completed fellowships in quantum pharmacology at Oxford University and in biophysics at Rochester University.
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Executive Vice President Drug Innov.& Realiz, Cso |
Current |
| Vertex Pharmaceuticals Incorporated |
Senior Vice President |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Chief Compliance Officer |
Current |
| Vertex, Inc. |
|
Current |
| Columbia Laboratories, Inc. |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Vice President |
Former |
| Vertex Pharmaceuticals Incorporated |
Deputy General Counsel |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Executive Vice President, Strategic & Corp Development |
Current |
| Bioexec Ventures, LLC |
Executive Vice President, Strategic & Corporate Development, Vertex Pharmaceuticals, Inc. |
Current |
| Biotech Turnaround Fund Bv |
|
Current |
| Vertex, Inc. |
Senior Vice President |
Former |
| Boehringer Ingelheim Corporation |
Vice President |
Former |
| Sandoz Pharmaceuticals Corporation |
Vice President |
Former |
| University of Bonn |
Doctor of Medicine |
Former |
| Macalester College |
Bachelor of Science in Biology |
Former |
Mr. Sachdev joined Vertex in July 2007 and currently serves as our Senior Vice President, Corporate Affairs and Public Policy. In this role, he leads our corporate communications, government affairs and public policy functions.
Mr. Sachdev came from Biotechnology Industry Organization (BIO) where he served as Executive Vice President, Health. At BIO, he was the senior executive responsible for managing BIO’s health policy department and its Governing Board. Mr. Sachdev is the former Deputy Commissioner for Policy at the U.S. Food and Drug Administration (FDA) where he also held several other senior appointments from 2002 to 2005. At FDA, he oversaw the development of all FDA policies, regulations and legislation.
From 1998 to 2002, Mr. Sachdev served as Majority Counsel to the Committee on Energy and Commerce in the U.S. House of Representatives. From 1993 to 1997, Mr. Sachdev practiced law, first at the Chemical Manufacturers Association, and then with the law firm of Ropes and Gray. Mr. Sachdev received a B.S from Carnegie Mellon University, and a J.D. from Emory University School of Law.
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Senior Vice President, Public Policy,Gov Affairs |
Current |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
Mr. Boger currently serves as our Senior Vice President and General Counsel, a position he has held since 2001. He came to Vertex from the law firm of Kirkpatrick & Lockhart LLP, where he was a partner specializing in business and corporate law and a member of the firm’s Management Committee. Mr. Boger holds an A.B. in History from Duke University, an M.B.A. from the Graduate School of Business at the University of Chicago and a J.D. from Boston College Law School.
Prior to the merger of Kirkpatrick & Lockhart with the Boston law firm of Warner & Stackpole LLP in 1999, Mr. Boger was a partner at Warner & Stackpole, where he served on its Executive Committee from 1988 to 1997. Mr. Boger served in the United States Army for three years and was honorably discharged with the rank of 1st Lieutenant, following service in Vietnam as the leader of a Mobile Advisory Team working with Vietnamese armed forces.
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
General Counsel & Senior Vice President |
Current |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Boston College |
J.D. |
Former |
| Duke University |
A.B. In History |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Senior Vice President, Human Resources |
Current |
Mr. Garrison, our Senior Vice President and Catalyst, joined Vertex in December 2005. From June 2001 to December 2005, Mr. Garrison was the founder and President of Bink Inc., a strategic consulting firm. Prior to that, Mr. Garrison spent 18 years as Chairman and CEO of Ingalls, Quinn & Johnson, one of New England’s largest advertising agencies. Mr. Garrison holds a B.A in English from Princeton University.
“On the back of my business card, you’ll find a definition of catalyst: A substance that modifies (especially increases) the rate of reaction. One that precipitates a process or event. That’s me. My role is to help people accelerate change and improvements.”
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Senior Vice President and Catalyst |
Current |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Managing Director, Vertex Pharmaceuticals Limited & Vice President, European Operations |
Current |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Vice President & Controller |
Current |
| Vertex Pharmaceuticals Incorporated |
Controller |
Former |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Vice President, Corp and Business Development |
Current |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Vice President, Investor Relations |
Current |
| Vertex Pharmaceuticals Incorporated |
Director, Corp Communications |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Vice President and Corporate Controller (Principal Accounting Officer) |
Current |
| Organization |
Position |
Status |
| Vertex, Inc. |
Founder |
Current |
| Vertex Pharmaceuticals Incorporated |
Founder |
Current |
| Progressive Business Leaders Network |
Board of Directors |
Current |
| Wesleyan University |
Trustee |
Current |
| Vertex Pharmaceuticals Incorporated |
Chief Executive Officer |
Former |
| Vertex Pharmaceuticals Incorporated |
President |
Former |
| Harvard University |
Doctorate Degrees In Chemistry |
Former |
| Harvard University |
Master's |
Former |
| Wesleyan University |
Bachelor of Arts In Chemistry and Philosophy |
Former |
Joshua Boger, Ph.D. founded Vertex Pharmaceuticals in 1989. Dr. Boger was our Chief Executive Officer from 1992 until May 2009. He served in the additional role of Chairman of the Board from 1997 until 2006. Dr. Boger began his industry career at Merck in 1978 and immediately before he founded Vertex was Senior Director of Basic Chemistry at Merck Sharp & Dohme Research Laboratories. Dr. Boger holds a B.A. in chemistry and philosophy from Wesleyan and M.S. and Ph.D. degrees in chemistry from Harvard University.
| Organization |
Position |
Status |
| Vertex, Inc. |
Chief Executive Officer |
Current |
| Nehi |
Founder |
Current |
| Vertex Pharmaceuticals Incorporated |
Founder |
Current |
| Massachusetts High Technology Council, Inc |
Chairman |
Current |
| Nehi |
Secretary |
Current |
| The Hastings Center |
Board of Directors |
Current |
| Activbiotics Inc. |
Board of Directors |
Current |
| Progressive Business Leaders Network |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Wesleyan University |
Trustee |
Current |
| Vertex Pharmaceuticals Incorporated |
Director and Chief Executive Officer (Principal Executive Officer) |
Former |
| Activbiotics Inc. |
Dr. Boger Is Chairman and Chief Executive Officer of Vertex Pharmaceuticals |
Former |
| Vertex Pharmaceuticals Incorporated |
President |
Former |
| Vertex, Inc. |
Chief Scientific Officer |
Former |
| Vertex, Inc. |
Founder |
Former |
| Vertex Pharmaceuticals Incorporated |
Chairman |
Former |
| Harvard University |
Ph.D. Degree In Chemistry |
Former |
| Harvard University |
Master's |
Former |
| Wesleyan University |
Bachelor of Arts In Chemistry and Philosophy |
Former |
| Harvard University |
B.A. In Chemistry |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Associate Director, Investor Relations |
Current |
| Vertex Pharmaceuticals Incorporated |
Manager, Investor Relations |
Former |
Majda Benhayoun, Ph.D. is currently Director of Program and Portfolio Management at Vertex Pharmaceuticals and has been working in drug development for the past 3 years. Prior to joining Vertex, Majda worked in Clinical Project Management for more than 15 years, with her first 11 years at Aventis Pharma, previously Rhone-Poulenc Rorer, and then 4 years at PAREXEL International where she held a position of Clinical Project Director. Majda has extensive experience in project management both strategic and operational in early and late stages of drug development in various therapeutic areas, some of them being CNS, inflammation, or immunology. As Clinical Program Manager, Majda has a broad experience in the concepts of clinical trials including planning and execution of clinical trials from single site Phase I to large and complex multinational Phase III trials concluding in NDA/MAA filing.
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Director of Program and Portfolio Management |
Current |
| Barnett International |
|
Current |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Director of Public Relations |
Current |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Director, Advisory |
Current |
| Vertex Pharmaceuticals Incorporated |
Director, Advisory |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Director, Corp Communications |
Current |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Media Relations Manager |
Current |
| Organization |
Position |
Status |
| The University of North Carolina |
Trustee |
Current |
| marketRx Inc. |
|
Current |
| Feinstein Kean Healthcare |
|
Current |
| Vertex Pharmaceuticals Incorporated |
Chairman of the Board |
Current |
| Liposcience, Inc. |
Chairman of the Board |
Current |
| Venrock Associates |
Chairman of the Board of Directors |
Current |
| Icagen, Inc. |
Chairman |
Current |
| Project Hope |
Chairman |
Former |
| Pharmacopeia Drug Discovery Inc. |
Board of Directors |
Current |
| Radius Ventures, LLC |
Board of Directors |
Current |
| Genentech, Inc. |
Director |
Current |
| Csis Inc |
Board of Directors |
Current |
| Cephalon, Inc. |
Board of Directors |
Current |
| Trimeris, Inc. |
Director |
Current |
| Icagen, Inc. |
Board of Directors |
Current |
| Drug Safety Alliance, Inc. |
Board of Directors |
Current |
| Kendle International Inc. |
Director |
Current |
| Scios, Inc. |
Director |
Current |
| Reata Pharmaceuticals, Inc |
Board of Directors |
Current |
| Epiphany Biosciences, Inc. |
Board of Directors |
Current |
| Staffmark |
Board of Directors |
Current |
| Personalized Medicine Coalition |
Board of Directors |
Current |
| Science & Technology Group |
CEO |
Former |
| Massachusetts Gen Hospital |
General Director |
Former |
| Massachusetts General Hospital |
General Director |
Former |
| Harvard Medical School |
director of Massachusetts General Hospital |
Former |
| Harvard Medical School |
Professor of Medicine |
Former |
| Meredith College |
trustee |
Former |
| Scios Inc. |
|
Former |
| New York Academy of Sciences |
Chairman |
Former |
| The Commonwealth Fund |
Chairman |
Former |
| Genaera Corporation |
Board of Directors |
Former |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Squibb Corporation |
Board Member |
Former |
| Squibb Corporation |
Vice Chairman |
Former |
| Massachusetts General Hospital |
Director |
Former |
| Biopure Corporation |
Director |
Former |
| The University of Texas Southwestern Medical School |
M.D. |
Former |
| The University of Texas |
|
Former |
| Organization |
Position |
Status |
| Broadcom Corporation |
Chief Financial Officer |
Current |
| Broadcom Korea |
Chief Financial Officer |
Current |
| Vertex Pharmaceuticals Incorporated |
Chair |
Current |
| Dentsply International Inc. |
Director |
Current |
| Vertex Pharmaceuticals Incorporated |
Committee Member |
Current |
| The Boston Consulting Group, Inc. |
Vice President |
Former |
| The Boston Consulting Group, Inc. |
Partner |
Former |
| The Boston Consulting Group, Inc. |
senior member |
Former |
| Allergan, Inc. |
|
Former |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Former |
| Harvard University |
M.B.A. |
Former |
| Harvard Business School |
M.B.A. |
Former |
| Massachusetts Institute of Technology |
bachelor of science in chemical engineering |
Former |
| Massachusetts, Inc. |
B.S. In Chemical Engineering |
Former |
| Organization |
Position |
Status |
| Drug Discovery World |
Consultant Editor |
Current |
| Vertex Pharmaceuticals Incorporated |
Committee Chair for Management Development and Compensation Committee |
Current |
| Psimedica |
Chairman |
Current |
| Vertex Pharmaceuticals Incorporated |
Director |
Current |
| Psivida Limited |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Committee Member |
Current |
| University of Bristol |
D.Sc. Degrees In Pharmacology |
Former |
| Organization |
Position |
Status |
| Charles River Ventures, Inc. |
partner |
Current |
| Vertex Pharmaceuticals Incorporated |
Director |
Current |
| Celerica, Inc. |
Director |
Current |
| Nantero |
Board of Directors |
Current |
| Accelerated Cure Project |
Board of Directors |
Current |
| Acopia Networks, Inc. |
Board of Directors |
Current |
| Cedar Point Communications, Inc. |
Board of Directors |
Current |
| Carrier Iq |
Board of Directors |
Current |
| Parascale |
Board of Directors |
Current |
| M2Z Networks, Inc |
Board of Directors |
Current |
| Icontrol Incorporated |
Director |
Current |
| Vertex Pharmaceuticals Incorporated |
Committee Member |
Current |
| Stratus Computer, Inc. |
CEO |
Former |
| Stratus Inc |
CEO |
Former |
| Stratus Inc |
President |
Former |
| Stratus Computer, Inc. |
President |
Former |
| Ascend |
Executive Vice President |
Former |
| Bay Networks |
executive vice president |
Former |
| Ascend |
General Manager |
Former |
| Bay Networks |
General Manager |
Former |
| AT&T Bell Laboratories |
NA |
Former |
| BigBand Networks, Inc. |
Board of Directors |
Former |
| Flarion Technologies, Inc. |
Board Member |
Former |
| Arrowpoint Corporation |
Board of Directors |
Former |
| Cport.Com, LLC |
Board of Directors |
Former |
| Riverdelta Networks, Inc. |
Board Member |
Former |
| American Internet Corporation |
Board of Directors |
Former |
| Riverdelta Networks, Inc. |
Investor |
Former |
| Flarion Technologies, Inc. |
Investor |
Former |
| Cornell University |
master of engineering in electrical engineering |
Former |
| Northeastern University |
MBA Degree |
Former |
| Bucknell University |
BS Degree In Electrical Engineering |
Former |
| Northeastern University |
BSEE degrees |
Former |
| Organization |
Position |
Status |
| Alfacell Corp |
Member, Board of Directors |
Current |
| Bio Transplant Incorporated |
Member, Board of Directors |
Current |
| Cytotherapeutics, Inc. |
Board of Directors |
Current |
| Onconase |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| inVentiv Health Inc. |
Board of Directors |
Current |
| Schering-Plough Corporation |
Executive Vice President |
Former |
| Schering-Plough Corporation |
Senior Executive |
Former |
| Schering-Plough Corporation |
Chairman, Health Care Products Division |
Former |
| Schering-Plough Healthcare Products Corp. |
Chairman |
Former |
| Rutgers University |
MBA degree |
Former |
| Williams College |
B.A. |
Former |
In 2005, Dr. Cordes became the first person to join our Board of Directors from our Scientific Advisory Board. Dr. Cordes has more than 40 years experience in the pharmaceutical industry as a researcher, executive and strategic advisor.
Formerly Chairman of Vitae Pharmaceuticals, Inc., from January 2002 until March 2006. Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. Dr. Cordes received a B.S. degree in chemistry from the California Institute of Technology and a Ph.D. in biochemistry from Brandeis University.
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Committee Member |
Current |
| Vitae Pharmaceuticals, Inc. |
Chairman |
Former |
| Brandeis University |
Ph.D. In Biochemistry |
Former |
| Organization |
Position |
Status |
| Theravance, Inc. |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Phase Forward Incorporated |
Board of Directors |
Current |
| AnorMED, Inc. |
Board of Directors |
Current |
| Merck & Co. Inc. |
chief safety officer |
Former |
| Merck & Co. Inc. |
Vice President, and later Senior Vice President of Clinical and Regulatory Development |
Former |
| Merck & Co. Inc. |
Executive Director of Biochemistry and Molecular Biology |
Former |
| Merck & Co. Inc. |
Senior Director |
Former |
| VaxGen, Inc. |
Board of Directors |
Former |
| Vassar College |
A.B. Degree |
Former |
| Organization |
Position |
Status |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Organization |
Position |
Status |
| Tioga Pharmaceuticals, Inc. |
Chairman & Acting CEO |
Current |
| Cabrellis Pharmaceuticals Corporation |
Partner, Forward Ventures |
Current |
| Southern California Inc |
Partner |
Current |
| Forward Ventures |
Partner |
Current |
| Oxagen Limited |
Non Executive Director |
Current |
| Novacardia, Inc |
Member of the Board of Directors |
Current |
| Forward Ventures |
Board of Directors |
Current |
| Oxagen Limited |
Director |
Current |
| Affinium Pharmaceuticals, Inc |
Director |
Current |
| Geneohm Sciences, Inc. |
Director |
Current |
| Cabrellis Pharmaceuticals Corporation |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Director |
Current |
| Technology Vision Group LLC |
Board of Directors |
Current |
| Asteres |
Director |
Current |
| Forward Ventures |
Member |
Current |
| Vertex Pharmaceuticals Incorporated |
Committee Member |
Current |
| Vertex Pharmaceuticals Incorporated |
Chief Executive Officer |
Former |
| Aurora Biosciences Corporation |
Chief Executive Officer |
Former |
| Aurora Biosciences Corporation |
President |
Former |
| Vertex Pharmaceuticals Incorporated |
President |
Former |
| The Boston Consulting Group, Inc. |
consultant |
Former |
| Aurora Biosciences Corporation |
Chairman of the Board |
Former |
| Vertex Pharmaceuticals Incorporated |
Chairman |
Former |
| Conforma Therapeutics Corporation |
Chairman of the Board |
Former |
| Tioga Pharmaceuticals, Inc. |
Director |
Former |
| Conforma Therapeutics Corporation |
Director |
Former |
| University of Oxford |
PhD. In Physical Chemistry |
Former |
| Harvard University |
MBA |
Former |
| Harvard Business School |
MBA |
Former |
Executive News
-
Big Brands Aim to Bolster U.S. AIDS Efforts
Reuters - 6/23/09 - View Story
-
Big Brands Aim to Bolster U.S. AIDS Efforts
Business Wire - 6/23/09 - View Story
-
UPDATE 1-Vertex sees profit soon after hep C drug launch-CEO
Reuters - 6/10/09 - View Story
-
BigBand Expands Relations With China's Jiangsu Cable
Broadcast Newsroom - 6/09/09 - View Story
-
BigBand Directors Depart
Light Reading - 6/09/09 - View Story
-
Vertex Pharmaceuticals Announces Agreements to Exchange an Additional $40.2 Million of its 2013...
Forbes.com - 6/08/09 - View Story
-
Vertex Pharmaceuticals Announces Agreements to Exchange $103.3 Million of its 2013 Convertible...
Forbes.com - 6/08/09 - View Story
-
BigBand Networks Announces Changes to Board of Directors
Business Wire - 6/08/09 - View Story
-
Drexel to Celebrate Commencement in Four Ceremonies on June 13
Forbes.com - 6/05/09 - View Story
-
Sarah Reed Rejoins Charles River Ventures as General Counsel
PR Newswire - 6/04/09 - View Story